source
- STAT+: Pharmalittle: We’re reading about a GSK deal for a drug from China, job losses in the U.S., and moreGSK has continued its drive to bulk up its pipeline, taking global rights to a multiple myeloma treatment developed in China
- NIH now allows businesses to apply for its research fundingThe National Institutes of Health announced that companies are eligible to submit grant applications, expanding the pool of potential research partners. This change aims to foster collaboration bet…